Conference Correspondent

Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor

Conference Correspondent 

Hope S. Rugo, MD, describes how she would treat a patient with HER-positive metastatic breast cancer that has progressed with a CDK4/CDK6 inhibitor plus an aromatase inhibitor.

Related Items


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: